Pfizer Global Manufacturing is shaking up its facilities around the world and reconfiguring their networks. The company has decided to close facilities in eight locations and reduce the workforce in six others by 2015 in an effort to improve efficiency and production processes and lower costs.
“The restructuring of our global plant network is critical to our efforts to remain competitive so that we can continue to meet patient needs and expand the access and affordability of our medicines,” said Pfizer Global Manufacturing President Nat Ricciardi in a statement.
Pfizer plans to close two facilities in Puerto Rico, three in Ireland, and three in the United States, including two in New York and one in Virginia. The company will begin to close facilities in 18 months at the aforementioned sites. Reductions are recommended at the following sites: Puerto Rico, Ireland, UK, Germany, and two sites in the U.S. including Massachusetts and North Carolina. Though the process will begin in 18 months or so, the timing for each recommended location will be contingent upon the complexity and timing issues of each specific plant.
Though the facility closures will make 6,000 jobs redundant over the next few years, Pfizer will keep the employees affected in mind during the transition period. “We are keenly aware of the impact these types of changes have on employees and their families,” Mr. Ricciardi said. “We will provide support to our colleagues who lose their jobs so that their transition to new careers is as smooth as possible.”
Source: Pfizer Global Manufacturing
“The restructuring of our global plant network is critical to our efforts to remain competitive so that we can continue to meet patient needs and expand the access and affordability of our medicines,” said Pfizer Global Manufacturing President Nat Ricciardi in a statement.
Pfizer plans to close two facilities in Puerto Rico, three in Ireland, and three in the United States, including two in New York and one in Virginia. The company will begin to close facilities in 18 months at the aforementioned sites. Reductions are recommended at the following sites: Puerto Rico, Ireland, UK, Germany, and two sites in the U.S. including Massachusetts and North Carolina. Though the process will begin in 18 months or so, the timing for each recommended location will be contingent upon the complexity and timing issues of each specific plant.
Though the facility closures will make 6,000 jobs redundant over the next few years, Pfizer will keep the employees affected in mind during the transition period. “We are keenly aware of the impact these types of changes have on employees and their families,” Mr. Ricciardi said. “We will provide support to our colleagues who lose their jobs so that their transition to new careers is as smooth as possible.”
Source: Pfizer Global Manufacturing
